Login / Signup

Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus-Cost effectiveness of outpatient treatment.

Marc-Nicolas RentinckRenate KrügerPia-Alice HoppeDaniel HummeMichaela NiebankAnna PokrywkaMiriam Songa StegemannAxel KolaLeif Gunnar HanitschRasmus Leistner
Published in: PloS one (2021)
Our data shows that outpatient decolonization offers a highly cost-effective secondary prevention strategy, which may prevent costly inpatient treatments. Therefore, health insurance companies should consider providing coverage of outpatient treatment of recurrent PVL-SA skin and soft tissue infections.
Keyphrases
  • health insurance
  • soft tissue
  • staphylococcus aureus
  • methicillin resistant staphylococcus aureus
  • affordable care act
  • mental health
  • palliative care
  • artificial intelligence